Dr Reddy’s goes beyond generic products, gets nod for two branded drugs - Feedback

Dr Reddy’s Laboratories has received the US Food and Drug Administration’s approval for two new drugs in three days, in a sign that top Indian drug makers might be looking to move beyond generics to come out with some original drugs of their own.

Just a couple of days after the Hyderabad-based drug maker received FDA approval for anti-migraine injection Zembrace, it has got the US regulator’s tentative approval for skin treatment drug Zenavod. The approvals have come at a time when Indian drug companies are facing the FDA’s ire for non-compliance of good manufacturing process.


About news

We take care of publishing the latest investment news and highlights for Feedback

Leave a Reply

Your email address will not be published. Required fields are marked *